Clinical utility of liquid biopsy in distinguishing true progression from radiation necrosis and pseudoprogression in malignant brain tumor.
Blood tests may help brain tumor doctors distinguish real cancer growth from harmless scar tissue, solving a frustrating problem where current imaging often fails them.
This systematic review examines the evidence for liquid biopsy in distinguishing true tumor progression from radiation necrosis and pseudoprogression in malignant brain tumor patients. This addresses a critical clinical gap where current imaging-based approaches are often insufficient.
What the study was
- Study design
- Systematic review
- Population
- Patients with malignant brain tumors undergoing radiation therapy
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Journal of Neuro-Oncology
Why it surfaced
Systematic review addressing a clinically important diagnostic gap in neuro-oncology. Liquid biopsy for treatment response monitoring is an evolving area with high unmet need.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.